Veterinary Medicine Information website

BIAMULINE

Authorised
  • Tiamulin hydrogen fumarate

Product identification

Medicine name:
BIAMULINE
Active substance:
  • Tiamulin hydrogen fumarate
Target species:
  • Turkey
  • Pig
  • Chicken
  • Chicken (broiler)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tiamulin hydrogen fumarate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Turkey
      • Meat and offal
        4
        day
    • Pig
      • Meat and offal
        4
        day
    • Chicken
      • Meat and offal
        1
        day
      • Eggs
        0
        day
    • Chicken (broiler)
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratoires Biove
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoires Biove
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6346525 7/2013
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 13/02/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025

fr-puar-600000040463-np-rpe_95-fr.pdf

French (PDF)
Published on: 7/01/2026
Download